Federal investigation sought to determine source of prescription pain medication shortages

Share this article:
Sen. Charles Grassley (R-IA)
Sen. Charles Grassley (R-IA)

Top U.S. lawmakers are concerned that overregulation of prescription pain medications is causing an inadvertent shortage of the controlled — and often necessary — controlled substances.

Sens. Charles Grassley (R-IA) and Sheldon Whitehouse (D-RI) asked the Government Accountability Office to find out if a federal Drug Enforcement Agency limit on the production of controlled substances is causing a shortage. Current DEA laws set limits for drug makers on the volume of controlled substances they produce. These drugs include prescription painkillers and tranquilizers, drugs that are commonly used to treat nursing home residents.

The senators, both of whom sit on the Senate Judiciary Committee, said that prescription painkillers and tranquilizers appear often on the Food and Drug Administration's drug shortage list.

“The Drug Enforcement Administration has to walk a fine line between managing dangerous controlled substances like painkillers and making sure there are adequate supplies for legitimate medicine,” Grassley, the ranking committee member, wrote in his letter to the GAO.

Lawmakers such as Sen. Herb Kohl (D-WI) have been outspoken in advocating for nursing home residents who need access to these medications for pain management.

Click here to read the full letter.

Share this article:

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.